170 related articles for article (PubMed ID: 25518392)
1. [How to manage medical treatment during pregnancy and childbirth].
Shimizu Y
Nihon Rinsho; 2014 Nov; 72(11):2053-60. PubMed ID: 25518392
[TBL] [Abstract][Full Text] [Related]
2. Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Ghezzi A; Annovazzi P; Portaccio E; Cesari E; Amato MP
Expert Rev Clin Immunol; 2013 Jul; 9(7):683-91; quiz 692. PubMed ID: 23899239
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: management issues during pregnancy.
Ferrero S; Pretta S; Ragni N
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
[TBL] [Abstract][Full Text] [Related]
4. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
Lu E; Dahlgren L; Sadovnick A; Sayao A; Synnes A; Tremlett H
Mult Scler; 2012 Apr; 18(4):460-7. PubMed ID: 21914689
[TBL] [Abstract][Full Text] [Related]
5. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
Lu E; Wang BW; Guimond C; Synnes A; Sadovnick D; Tremlett H
Neurology; 2012 Sep; 79(11):1130-5. PubMed ID: 22933738
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
Sandberg-Wollheim M; Frank D; Goodwin TM; Giesser B; Lopez-Bresnahan M; Stam-Moraga M; Chang P; Francis GS
Neurology; 2005 Sep; 65(6):802-6. PubMed ID: 16093457
[TBL] [Abstract][Full Text] [Related]
7. [Neuroimmunological diseases and pregnancy].
Shimizu Y
Rinsho Shinkeigaku; 2012; 52(11):878-81. PubMed ID: 23196450
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
Thiel S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
Mult Scler; 2016 May; 22(6):801-9. PubMed ID: 26920382
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.
Amato MP; Portaccio E; Ghezzi A; Hakiki B; Zipoli V; Martinelli V; Moiola L; Patti F; La Mantia L; Mancardi GL; Solaro C; Tola MR; Pozzilli C; De Giglio L; Totaro R; Lugaresi A; Di Tommaso V; Paolicelli D; Marrosu MG; Comi G; Pellegrini F; Trojano M;
Neurology; 2010 Nov; 75(20):1794-802. PubMed ID: 21079181
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy and Family Planning in Multiple Sclerosis.
Langer-Gould AM
Continuum (Minneap Minn); 2019 Jun; 25(3):773-792. PubMed ID: 31162316
[TBL] [Abstract][Full Text] [Related]
11. [Interferon-beta treatment for multiple sclerosis and predictors of response].
Kohriyama T; Ochi K; Matsumoto M
Nihon Rinsho; 2008 Jun; 66(6):1119-26. PubMed ID: 18540357
[TBL] [Abstract][Full Text] [Related]
12. [Multiple sclerosis and pregnancy].
Ruuskanen J; Malm H; Airas L
Duodecim; 2013; 129(14):1457-64. PubMed ID: 23961604
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and pregnancy.
Tsui A; Lee MA
Curr Opin Obstet Gynecol; 2011 Dec; 23(6):435-9. PubMed ID: 22011954
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy.
Sandberg-Wollheim M; Alteri E; Moraga MS; Kornmann G
Mult Scler; 2011 Apr; 17(4):423-30. PubMed ID: 21220368
[TBL] [Abstract][Full Text] [Related]
15. [Interferon beta treatment in multiple sclerosis].
Ochi H
Nihon Rinsho; 2003 Aug; 61(8):1367-73. PubMed ID: 12962025
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Bonafede MM; Johnson BH; Wenten M; Watson C
Clin Ther; 2013 Oct; 35(10):1501-12. PubMed ID: 24139422
[TBL] [Abstract][Full Text] [Related]
17. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
MacDonald SC; McElrath TF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
[TBL] [Abstract][Full Text] [Related]
18. Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Lu E; Wang BW; Guimond C; Synnes A; Sadovnick AD; Dahlgren L; Traboulsee A; Tremlett H
Expert Rev Neurother; 2013 Mar; 13(3):251-60; quiz 261. PubMed ID: 23448215
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
Stuart WH
J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S19-25. PubMed ID: 15253686
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy in the Setting of Multiple Sclerosis.
Fabian M
Continuum (Minneap Minn); 2016 Jun; 22(3):837-50. PubMed ID: 27261685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
